敗血症診断薬の世界市場（2022年）

世界の敗血症診断の市場規模は、2021年に5億8,760万米ドルとなりました。

同市場は、2021年～2026年にかけて7.3％のCAGRで拡大し、2026年には8億3,700万米ドルに達すると予測されています。

当レポートでは、世界の敗血症診断市場について調査し、市場の概要とともに、技術別、製品別、手法別、検査タイプ別、病原体タイプ別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 まとめとハイライト

第3章 技術の背景

• イントロダクション
• 原因
• 危険因子
• 症状
• 病態生理学
• 内皮機能障害
• 凝固障害
• 心血管機能障害
• 細胞機能障害
• 疫学と経済的負担
• 診断と治療
• 規制シナリオ
• 北米の規制
• 欧州の規制

第4章 市場力学

• 敗血症診断市場に影響を与える要因
• 市場の促進要因
• 市場の抑制要因
• 市場の機会

第5章 COVID-19の影響

第6章 敗血症診断市場、技術別

• 技術別世界の敗血症診断市場
• 微生物学的検査
• 免疫学的検査
• 分子診断
• その他

第7章 敗血症診断市場、製品別

• アッセイと試薬
• 培地
• 装置
• ソフトウェア

第8章 敗血症診断市場、手法別

• 従来型診断
• 自動診断

第9章 敗血症診断市場、検査タイプ別

• 検査室での検査
• ポイントオブケア検査

第10章 敗血症診断市場、病原体タイプ別

• 細菌性敗血症
• 真菌性敗血症
• その他

第11章 敗血症診断市場、エンドユーザー別

• 病院とクリニック
• 診断センター
• 学術・研究機関

第12章 敗血症診断市場、地域別

• 北米
• 欧州
• アジア太平洋
• その他の地域

第13章 競合情勢と市場機会の分析

第14章 企業プロファイル

• ABBOTT LABORATORIES
• AXIS-SHIELD DIAGNOSTICS LTD.
• BECTON, DICKINSON & COMPANY
• BIOMERIEUX
• BRUKER CORP.
• DANAHER
• EKF DIAGNOSTICS HOLDINGS PLC
• IMMUNEXPRESS
• LUMINEX CORP.
• QIAGEN NV
• ROCHE DIAGNOSTICS CORP.
• SEEGENE
• SIEMENS HEALTHINEERS AG
• T2 BIOSYSTEMS
• THERMO FISHER SCIENTIFIC INC.

List of Tables

• Summary Table B : Global Sepsis Diagnostic Market, by Region, Through 2026
• Summary Table A : Global Sepsis Diagnostic Market, Through 2026
• Table 1 : Diagnostic Test Types and Regulation
• Table 2 : COVID-19 Clinical Symptom Distribution
• Table 3 : COVID-19 Confirmed Cases and Deaths, by WHO Region, April 1, 2022
• Table 4 : Global Sepsis Diagnostic Market, Through 2026
• Table 5 : Global Sepsis Diagnostic Market, by Technology, Through 2026
• Table 6 : Global Sepsis Diagnostic Market for Microbiological Tests, by Region, Through 2026
• Table 7 : Global Sepsis Diagnostic Market for Immunoassays, by Region, Through 2026
• Table 8 : Global Sepsis Diagnostic Market for Molecular Diagnosis, by Region, Through 2026
• Table 9 : Global Sepsis Diagnostic Market for Other Technology, by Region, Through 2026
• Table 10 : Global Sepsis Diagnostic Market, by Product Type, Through 2026
• Table 11 : Global Sepsis Diagnostic Market for Assays and Reagents, by Region, Through 2026
• Table 12 : Global Sepsis Diagnostic Market for Culture Media, by Region, Through 2026
• Table 13 : Global Sepsis Diagnostic Market for Instruments, by Region, Through 2026
• Table 14 : Global Sepsis Diagnostic Market for Software, by Region, Through 2026
• Table 15 : Global Sepsis Diagnostic Market, by Method Type, Through 2026
• Table 16 : Global Sepsis Diagnostic Market for Conventional Methods, by Region, Through 2026
• Table 17 : Global Sepsis Diagnostic Market for Automated Methods, by Region, Through 2026
• Table 18 : Global Sepsis Diagnostic Market, by Test Type, Through 2026
• Table 19 : Global Sepsis Diagnostic Market for Laboratory Tests, by Region, Through 2026
• Table 20 : Global Sepsis Point-of-Care Test Diagnostic Market, by Region, Through 2026
• Table 21 : Global Sepsis Diagnostic Market, by Pathogen Type, Through 2026
• Table 22 : Global Bacterial Sepsis Market, by Region, Through 2026
• Table 23 : Global Fungal Sepsis Market, by Region, Through 2026
• Table 24 : Global Sepsis by Other Pathogens Market, by Region, Through 2026
• Table 25 : Global Sepsis Diagnostic Market, by End User, Through 2026
• Table 26 : Global Sepsis Diagnostic in Hospitals and Clinics Market, by Region, Through 2026
• Table 27 : Global Sepsis Diagnostics in Diagnostic Centers Market, by Region, Through 2026
• Table 28 : Global Sepsis Diagnostics in Academic and Research Institutions Market, by Region, Through 2026
• Table 29 : Global Sepsis Diagnostic Market, by Region, Through 2026
• Table 30 : Mergers, Acquisitions and Collaborations Portfolio, 2020-2022
• Table 31 : Abbott Laboratories: Business Segment
• Table 32 : Abbott Laboratories: Financials, 2018-2020
• Table 33 : Becton, Dickinson & Company: Business Segment
• Table 34 : Becton, Dickinson & Company: Financials, 2018-2020
• Table 35 : BioMerieux SA: Sepsis Product Portfolio
• Table 36 : BioMerieux SA: Financials, 2018-2020
• Table 37 : Bruker Corp.: Financials, 2018-2020
• Table 38 : Danaher: Business Segment
• Table 39 : Danaher: Financials, 2018-2020
• Table 40 : EKF Diagnostics Holdings PLC: Business Segment
• Table 41 : Luminex: Product Portfolio
• Table 42 : Roche Diagnostics Corp.: Product Segment
• Table 43 : Roche Diagnostics Corp.: Financial Performance, 2018-2020
• Table 44 : Roche Diagnostics Corp.: Key Developments
• Table 45 : Siemens Healthineers AG: Business Segment
• Table 46 : T2 Biosystems: Product Portfolio
• Table 47 : T2 Biosystems: Key Developments
• Table 48 : Thermo Fisher Scientific Inc.: Business Segments
• Table 49 : Thermo Fisher Scientific Inc.: Financial Performance, 2018-2020

List of Figures

• Summary Figure A : Global Sepsis Diagnostic Market, 2019-2026
• Summary Figure B : Global Sepsis Diagnostic Market, by Region, 2019-2026
• Figure 1 : Sepsis Definition
• Figure 2 : Sepsis Pathophysiology
• Figure 3 : Global Sepsis Diagnostic Market, by Technology, 2019-2026
• Figure 4 : Global Sepsis Diagnostic Market Share, by Technology, 2020
• Figure 5 : Global Sepsis Diagnostic Market for Microbiological Tests, by Region, 2019-2026
• Figure 6 : Global Sepsis Diagnostic Market for Immunoassays, by Region, 2019-2026
• Figure 7 : Global Sepsis Diagnostic Market for Molecular Diagnosis, by Region, 2019-2026
• Figure 8 : Global Sepsis Diagnostic Market for Other Technology, by Region, 2019-2026
• Figure 9 : Global Sepsis Diagnostic Market, by Product Type, 2019-2026
• Figure 10 : Global Market Share for Sepsis Diagnostics, by Product Type, 2020
• Figure 11 : Global Sepsis Diagnostic Assay and Reagent Market, by Region, 2019-2026
• Figure 12 : Global Sepsis Diagnostic Market for Culture Media, by Region, 2019-2026
• Figure 13 : Global Sepsis Diagnostic Market for Instruments, by Region, 2019-2026
• Figure 14 : Global Sepsis Diagnostic Market for Software, by Region, 2019-2026
• Figure 15 : Global Sepsis Diagnostic Market, by Method Type, 2019-2026
• Figure 16 : Global Sepsis Diagnostic Market Share, by Method Type, 2020
• Figure 17 : Global Sepsis Diagnostic Market for Conventional Methods, by Region, 2019-2026
• Figure 18 : Global Sepsis Diagnostic Market for Automated Methods, by Region, 2019-2026
• Figure 19 : Global Sepsis Diagnostic Market, by Test Type, 2019-2026
• Figure 20 : Global Sepsis Diagnostic Market Share, by Test Type, 2020
• Figure 21 : Global Sepsis Diagnostic Market for Laboratory Tests, by Region, 2019-2026
• Figure 22 : Global Sepsis Point-of-Care Test Diagnostic Market, by Region, 2019-2026
• Figure 23 : Global Sepsis Diagnostic Market, by Pathogen Type, 2019-2026
• Figure 24 : Global Sepsis Diagnostics Market Share, by Pathogen Type, 2020
• Figure 25 : Global Bacterial Sepsis Market, by Region, 2019-2026
• Figure 26 : Global Fungal Sepsis Market, by Region, 2019-2026
• Figure 27 : Global Sepsis by Other Pathogens Market, by Region, 2019-2026
• Figure 28 : Global Sepsis Diagnostics Market, by End User, 2019-2026
• Figure 29 : Global Sepsis Diagnostics Market Share, by End User, 2020
• Figure 30 : Global Sepsis Diagnostics in Hospitals and Clinics Market, by Region, 2019-2026
• Figure 31 : Global Sepsis Diagnostics in Diagnostic Centers, by Region, 2019-2026
• Figure 32 : Global Sepsis Diagnostics in Academic and Research Institutions Market, by Region, 2019-2026
• Figure 33 : Global Sepsis Diagnostic Market, by Region, 2019-2026
• Figure 34 : Global Sepsis Diagnostic Market Share, by Region, 2020
• Figure 35 : Global Sepsis Diagnostic Market Share, by Key Manufacturers and Suppliers, 2020
• Figure 36 : Abbott Laboratories: Annual Revenue, 2018-2020
• Figure 37 : Abbott Laboratories: Market Share, by Business Segment, 2020
• Figure 38 : Abbott Laboratories: Revenue Share, by Region, 2020
• Figure 39 : Abbott Laboratories: Diagnostics Segment Market Share, 2020
• Figure 40 : Becton, Dickinson & Company: Annual Revenue, 2018-2020
• Figure 41 : Becton, Dickinson & Company: Market Share, by Region, 2020
• Figure 42 : Becton, Dickinson & Company: Market Share, by Business Segments, 2020
• Figure 43 : BioMerieux SA: Annual Revenue, 2018-2020
• Figure 44 : BioMerieux SA: Market Share, by Business Segment, 2020
• Figure 45 : BioMerieux SA: Market Share, by Region, 2020
• Figure 46 : Bruker Corp.: Annual Revenue, 2018-2020
• Figure 47 : Bruker Corp.: Revenue Market Share, by Region, 2020
• Figure 48 : Bruker Corp.: Market Share, by Business Segment, 2020
• Figure 49 : Danaher: Annual Revenue, 2018-2020
• Figure 50 : Danaher: Diagnostic Segment Market Share, by Region/Market, 2020
• Figure 51 : Danaher: Market Share, by Business Segment, 2020
• Figure 52 : Roche Diagnostics Corp.: Annual Revenue, 2018-2020
• Figure 53 : Roche Diagnostics Corp.: Market Share, by Region, 2020
• Figure 54 : Roche Diagnostics Corp.: Market Share, by Business Segment, 2020
• Figure 55 : Siemens Healthineers AG: Annual Revenue, 2020 and 2021
• Figure 56 : Siemens Healthineers: Market Share, by Business Segment, 2021
• Figure 57 : Siemens Healthineers: Market Share, by Region, 2021
• Figure 58 : T2 Biosystems: Annual Revenue, 2018-2020
• Figure 59 : T2 Biosystems: Market Share, by Region, 2020
• Figure 60 : T2 Biosystems: Market Share, by Products, 2020
• Figure 61 : Thermo Fisher Scientific Inc.: Annual Revenue, 2018-2020
• Figure 62 : Thermo Fisher Scientific Inc.: Market Share, by Region, 2020
• Figure 63 : Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2021
• Figure 64 : Thermo Fisher Scientific Inc.: Market Share, by Product, 2020

Highlights:

The global sepsis diagnostic market should reach $837 million by 2026 from $587.6 million in 2021 at a compound annual growth rate (CAGR) of 7.3% for the forecast period of 2021 to 2026.

The North American sepsis diagnostic market is expected to grow from $283.8 million in 2021 to $417.1 million in 2026 at a CAGR of 8.0% for the forecast period of 2021 to 2026.

The European sepsis diagnostic market is expected to grow from $164.7 million in 2021 to $234.6 million in 2026 at a CAGR of 7.3% for the forecast period of 2021 to 2026.

Report Scope:

The current report provides detailed exposure to the sepsis diagnostic market. This report highlights the current and future market potential of sepsis diagnostics, as well as a detailed analysis of market drivers, challenges and opportunities. The report also covers market projections to 2026 and market shares for key market players. It details the market share of sepsis diagnostics based on technology type, product, diagnostic method and pathogen type. The report includes company profiles of the key players, with detailed information regarding their business segments, financials, product portfolios and recent developments. The report also provides the impact of the COVID-19 pandemic on this market.

The regional market has been segmented into North America, Europe, Asia-Pacific and the Rest of the world. For market estimates, data have been provided for 2019 as the historic year and 2020 as the base year, with a forecast for 2026.

Report Includes:

• 35 data tables and 15 additional tables
• An updated overview of the global sepsis diagnostics market
• Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
• Evaluation and forecast the global market size for sepsis diagnostics, and corresponding market share analysis by product, technology type, diagnostic method, test type, pathogen, end user and geographic region
• Highlights the current and future market potential of sepsis diagnostics along with a detailed analysis of the drivers, challenges, and opportunities in the market
• Identification of promising new products and technologies still in the development and assess the probability that they will be commercialized successfully in the next five years
• Discussion of the COVID-19 implications on the market for sepsis clinical diagnostics and research studies
• Information pertaining to the companies best positioned to meet this demand owing to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
• Insight into the recent industry structure, current competitive scenario, R&D activities, product launch strategies and company value share analysis based on their segmental revenues
• Descriptive company profiles of the leading global players, including Abbott Laboratories, Bruker Corp., Roche Diagnostics Corp., Siemens Healthineers AG and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Information Sources
• Methodology
• Geographic Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Technology Background

• Introduction
• Causes
• Risk Factors
• Symptoms
• Pathophysiology
• Endothelial Dysfunction
• Coagulopathy
• Cardiovascular Dysfunction
• Cellular Dysfunction
• Epidemiology and Economic Burden
• Diagnosis and Treatment
• Regulatory Scenario
• Regulations in North America
• European Regulations

Chapter 4 Market Dynamics

• Factors Affecting the Sepsis Diagnostic Market
• Market Drivers
• Increasing Incidence of Infectious Diseases
• Rising Aging Population and Increasing Incidence of Chronic Diseases
• Increasing Government Initiatives
• Technological Developments
• Market Restraints
• High Cost of Instruments and Lack of Skilled Workforce
• Opportunities
• Demand for Rapid and Accurate Diagnostic Tool

Chapter 5 Impact of COVID-19

• Introduction
• Outbreak
• COVID-19 Symptoms
• COVID-19 Progression
• Incubation Period
• Epidemiology
• Collaboration Between Organizations and Governments
• Spread of Disease
• Impact of COVID-19 on the Sepsis Diagnostic Market

Chapter 6 Sepsis Diagnostic Market by Technology

• Global Sepsis Diagnostic Market by Technology
• Microbiological Tests
• Immunoassays
• Molecular Diagnostics
• Others

Chapter 7 Sepsis Diagnostic Market by Product

• Assays and Reagents
• Culture Media
• Instruments
• Software

Chapter 8 Sepsis Diagnostic Market by Method

• Conventional Diagnostics
• Automated Diagnostics

Chapter 9 Sepsis Diagnostic Market by Test Type

• Laboratory Tests
• Point-of-Care Tests

Chapter 10 Sepsis Diagnostic Market by Pathogen Type

• Bacterial Sepsis
• Fungal Sepsis
• Others

Chapter 11 Sepsis Diagnostic Market by End User

• Hospitals and Clinics
• Diagnostic Centers
• Academic and Research Institutions

Chapter 12 Sepsis Diagnostic Market by Region

• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 13 Competitive Landscape and Analysis of Market Opportunities

• Recent Developments
• Mergers, Acquisitions and Collaborations
• Sepsis Diagnostic Company Market Shares

Chapter 14 Company Profiles

• ABBOTT LABORATORIES
• AXIS-SHIELD DIAGNOSTICS LTD.
• BECTON, DICKINSON & COMPANY
• BIOMERIEUX
• BRUKER CORP.
• DANAHER
• EKF DIAGNOSTICS HOLDINGS PLC
• IMMUNEXPRESS
• LUMINEX CORP.
• QIAGEN NV
• ROCHE DIAGNOSTICS CORP.
• SEEGENE
• SIEMENS HEALTHINEERS AG
• T2 BIOSYSTEMS
• THERMO FISHER SCIENTIFIC INC.